140 related articles for article (PubMed ID: 36455988)
1. Can digital adherence technologies reduce inequity in tuberculosis treatment success? Evidence from a randomised controlled trial.
Boutilier JJ; Yoeli E; Rathauser J; Owiti P; Subbaraman R; Jónasson JO
BMJ Glob Health; 2022 Dec; 7(12):. PubMed ID: 36455988
[TBL] [Abstract][Full Text] [Related]
2. Evaluating the equity impact and cost-effectiveness of digital adherence technologies with differentiated care to support tuberculosis treatment adherence in Ethiopia: protocol and analysis plan for the health economics component of a cluster randomised trial.
Foster N; Tadesse AW; McQuaid CF; Gosce L; Abdurhman T; Assefa D; Bedru A; Houben RMGJ; van Kalmthout K; Letta T; Mohammed Z; van Rest J; Umeta DG; Weldemichael GT; Yazew H; Jerene D; Quaife M; Fielding KL
Trials; 2023 Apr; 24(1):292. PubMed ID: 37095533
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of implementation and effectiveness of digital adherence technology with differentiated care to support tuberculosis treatment adherence and improve treatment outcomes in Ethiopia: a study protocol for a cluster randomised trial.
Tadesse AW; Mohammed Z; Foster N; Quaife M; McQuaid CF; Levy J; van Kalmthout K; van Rest J; Jerene D; Abdurhman T; Yazew H; Umeta DG; Assefa D; Weldemichael GT; Bedru A; Letta T; Fielding KL
BMC Infect Dis; 2021 Nov; 21(1):1149. PubMed ID: 34758737
[TBL] [Abstract][Full Text] [Related]
4. Feasibility and acceptability of the smart pillbox and medication label with differentiated care to support person-centered tuberculosis care among ASCENT trial participants - A multicountry study.
Tadesse AW; Mganga A; Dube TN; Alacapa J; van Kalmthout K; Letta T; Mleoh L; Garfin AMC; Maraba N; Charalambous S; Foster N; Jerene D; Fielding KL
Front Public Health; 2024; 12():1327971. PubMed ID: 38444445
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of digital adherence technologies in improving tuberculosis treatment outcomes in four countries: a pragmatic cluster randomised trial protocol.
Jerene D; Levy J; van Kalmthout K; Rest JV; McQuaid CF; Quaife M; Charalambous S; Gamazina K; Garfin AMC; Mleoh L; Terleieva Y; Bogdanov A; Maraba N; Fielding K
BMJ Open; 2023 Mar; 13(3):e068685. PubMed ID: 36918242
[TBL] [Abstract][Full Text] [Related]
6. Acceptability of a Digital Adherence Tool Among Patients With Tuberculosis and Tuberculosis Care Providers in Kilimanjaro Region, Tanzania: Mixed Methods Study.
Mtenga AE; Maro RA; Dillip A; Msoka P; Emmanuel N; Ngowi K; Sumari-de Boer M
Online J Public Health Inform; 2024 Jun; 16():e51662. PubMed ID: 38922643
[TBL] [Abstract][Full Text] [Related]
7. ImPROving TB outcomes by modifying LIFE-style behaviours through a brief motivational intervention followed by short text messages (ProLife): study protocol for a randomised controlled trial.
Moriarty AS; Louwagie GM; Mdege ND; Morojele N; Tumbo J; Omole OB; Bachmann MO; Kanaan M; Turner A; Parrott S; Siddiqi K; Ayo-Yusuf OA
Trials; 2019 Jul; 20(1):457. PubMed ID: 31349850
[TBL] [Abstract][Full Text] [Related]
8. Effect of a brief motivational interview and text message intervention targeting tobacco smoking, alcohol use and medication adherence to improve tuberculosis treatment outcomes in adult patients with tuberculosis: a multicentre, randomised controlled trial of the ProLife programme in South Africa.
Louwagie G; Kanaan M; Morojele NK; Van Zyl A; Moriarty AS; Li J; Siddiqi K; Turner A; Mdege ND; Omole OB; Tumbo J; Bachmann M; Parrott S; Ayo-Yusuf OA
BMJ Open; 2022 Feb; 12(2):e056496. PubMed ID: 35165113
[TBL] [Abstract][Full Text] [Related]
9. Study protocol and implementation details for a pragmatic, stepped-wedge cluster randomised trial of a digital adherence technology to facilitate tuberculosis treatment completion.
Crowder R; Kityamuwesi A; Kiwanuka N; Lamunu M; Namale C; Tinka LK; Nakate AS; Ggita J; Turimumahoro P; Babirye D; Oyuku D; Berger CA; Tucker A; Patel D; Sammann A; Dowdy D; Stavia T; Cattamanchi A; Katamba A
BMJ Open; 2020 Nov; 10(11):e039895. PubMed ID: 33247012
[TBL] [Abstract][Full Text] [Related]
10. Tuberculosis Monitoring Encouragement Adherence Drive (TMEAD): Toward improving the adherence of the patients with drug-sensitive tuberculosis in Nashik, Maharashtra.
Saha S; Saxena D; Raval D; Halkarni N; Doshi R; Joshi M; Sridharan M; Sathwara J; Yasobant S; Shah H; Quazi ZS; Rajsekar K; Chowdhury J
Front Public Health; 2022; 10():1021427. PubMed ID: 36620234
[TBL] [Abstract][Full Text] [Related]
11. Time Trend Analysis of Tuberculosis Treatment While Using Digital Adherence Technologies-An Individual Patient Data Meta-Analysis of Eleven Projects across Ten High Tuberculosis-Burden Countries.
de Groot LM; Straetemans M; Maraba N; Jennings L; Gler MT; Marcelo D; Mekoro M; Steenkamp P; Gavioli R; Spaulding A; Prophete E; Bury M; Banu S; Sultana S; Onjare B; Efo E; Alacapa J; Levy J; Morales MLL; Katamba A; Bogdanov A; Gamazina K; Kumarkul D; Ekaterina OL; Cattamanchi A; Khan A; Bakker MI
Trop Med Infect Dis; 2022 Apr; 7(5):. PubMed ID: 35622692
[TBL] [Abstract][Full Text] [Related]
12. Digital adherence technologies for the management of tuberculosis therapy: mapping the landscape and research priorities.
Subbaraman R; de Mondesert L; Musiimenta A; Pai M; Mayer KH; Thomas BE; Haberer J
BMJ Glob Health; 2018; 3(5):e001018. PubMed ID: 30364330
[TBL] [Abstract][Full Text] [Related]
13. Decision-support tools via mobile devices to improve quality of care in primary healthcare settings.
Agarwal S; Glenton C; Tamrat T; Henschke N; Maayan N; Fønhus MS; Mehl GL; Lewin S
Cochrane Database Syst Rev; 2021 Jul; 7(7):CD012944. PubMed ID: 34314020
[TBL] [Abstract][Full Text] [Related]
14. Current status and future prospects of TB digital treatment adherence technology use in China.
Ni N; Wang N; Veronese V; Wang MZ; Wang JW; Wang CH; Li T; Xia YY; Huang F; Zhao YL
Int J Tuberc Lung Dis; 2023 Jun; 27(6):438-443. PubMed ID: 37231604
[No Abstract] [Full Text] [Related]
15. Acceptability and feasibility of digital adherence technologies for drug-susceptible tuberculosis treatment supervision: A meta-analysis of implementation feedback.
Guzman K; Crowder R; Leddy A; Maraba N; Jennings L; Ahmed S; Sultana S; Onjare B; Shilugu L; Alacapa J; Levy J; Katamba A; Kityamuwesi A; Bogdanov A; Gamazina K; Cattamanchi A; Khan A
PLOS Digit Health; 2023 Aug; 2(8):e0000322. PubMed ID: 37582066
[TBL] [Abstract][Full Text] [Related]
16. Impact of a mobile phone-based interactive voice response software on tuberculosis treatment outcomes in Uganda (CFL-TB): a protocol for a randomized controlled trial.
Byonanebye DM; Mackline H; Sekaggya-Wiltshire C; Kiragga AN; Lamorde M; Oseku E; King R; Parkes-Ratanshi R
Trials; 2021 Jun; 22(1):391. PubMed ID: 34120649
[TBL] [Abstract][Full Text] [Related]
17. Bracelet- and self-directed observational therapy for control of tuberculosis: study protocol for a cluster randomized controlled trial.
Huang R; Ren G; Hu J
Trials; 2017 Jul; 18(1):286. PubMed ID: 28673323
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
